Skip to main content

Advertisement

Log in

Predictive factors in treatment response of malignant external otitis

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the prevalence and impact of various predictive factors including diabetes control in malignant external otitis (MEO) treatment response.

Methods

In a cross-sectional study on MEO patients, we defined treatment response with three indices; ESR level decrease, hospitalization period, and systemic antifungal drug usage. The impact of diabetes control and other predictive factors on these indices have been evaluated.

Results

Overall, 164 patients with a mean age of 67.8 ± 9.7 years were included. Cranial nerve involvement was present in 56 patients. Nine patients had immunodeficiency. 19.5% of cases had leukocytosis. Diabetes mellitus was present in 156 patients, suffering for an average of 13.9 ± 8.6 years. The overall mean hemoglobin A1C (HbA1c) level was 8.3% (4.4–12.8%), and the mean fasting blood sugar was 146.4 mg/dl (63–292 mg/dl). 29.3% of patients had good diabetes control before admission (HbA1c < 7%), 54.9% had poor control (7% < HbA1c < 10%) and 15.9% had very poor glycemic control (HbA1c > 10%). The predictive role for the following factors were not statistically significant: age, gender, comorbidities, diabetes, diabetes management method used before and during hospitalization, diabetes duration, leukocytosis, immunodeficiency, fasting blood sugar level, HbA1c level, glycemic control index, and insulin amount. However, CRP level with a mean value of 34.3 mg/L showed a significant correlation with ESR decrease, hospitalization period, and antifungal drug usage.

Conclusion

CRP level could be used as a predictor for the hospitalization period, the need for systemic antifungal and ESR level decrease. It would be helpful to check the CRP level at the time of diagnosis to predict the hospitalization period and the necessity of systemic antifungal management to adjust the treatment strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V (2007) Necrotizing external otitis: a report of 46 cases. Otol Neurotol 28(6):771–773. https://doi.org/10.1097/MAO.0b013e31805153bd

    Article  Google Scholar 

  2. Loh S, Loh WS (2013) Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors. Otolaryngol Head Neck Surg 148(6):991–996. https://doi.org/10.1177/0194599813482107

    Article  Google Scholar 

  3. Lee SK, Lee SA, Seon SW, Jung JH, Lee JD, Choi JY et al (2017) Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol. 10(3):228–235. https://doi.org/10.21053/ceo.2016.00612

    Article  Google Scholar 

  4. Carfrae MJ, Kesser BW (2008) Malignant otitis externa. Otolaryngol Clin N Am 41(3):537–549. https://doi.org/10.1016/j.otc.2008.01.004 (viii–ix)

    Article  Google Scholar 

  5. Nawas MT, Daruwalla VJ, Spirer D, Micco AG, Nemeth AJ (2013) Complicated necrotizing otitis externa. Am J Otolaryngol 34(6):706–709. https://doi.org/10.1016/j.amjoto.2013.07.003

    Article  Google Scholar 

  6. Dabiri S, Karrabi N, Yazdani N, Rahimian A, Kheiltash A, Hasibi M et al (2020) Facial nerve paralysis in malignant otitis externa: comparison of the clinical and paraclinical findings. Acta Otolaryngol 27:1–5. https://doi.org/10.1080/00016489.2020.1808242

    Article  CAS  Google Scholar 

  7. Sreepada GS, Kwartler JA (2003) Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 11(5):316–323. https://doi.org/10.1097/00020840-200310000-00002

    Article  Google Scholar 

  8. Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI (2008) Predicting outcome of malignant external otitis. Otol Neurotol 29(3):339–343. https://doi.org/10.1097/MAO.0b013e3181661879

    Article  Google Scholar 

  9. Orji FT, Akpeh JO, Ukaegbe OC (2017) Malignant otitis externa: an assessment of emerging pathogens and the prognostic factors. Int J Med Med Sci 9(7):86–91. https://doi.org/10.5897/IJMMS2017.1305

    Article  Google Scholar 

  10. Chin R, Roche P, Sigston E, Valance N (2012) Malignant otitis externa: an Australian case series. Surgeon 10(5):273–277. https://doi.org/10.1016/j.surge.2011.09.004

    Article  Google Scholar 

  11. Hine JL, de Lusignan S, Burleigh D, Pathirannehelage S, McGovern A, Gatenby P et al (2017) Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study. Diabet Med 34(4):551–557. https://doi.org/10.1111/dme.13205

    Article  CAS  Google Scholar 

  12. Casqueiro J, Casqueiro J, Alves C (2012) Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 16(Suppl 1):S27–S36. https://doi.org/10.4103/2230-8210.94253

    Article  Google Scholar 

  13. Hasibi M, Ashtiani MK, Motassadi Zarandi M, Yazdani N, Borghei P, Kuhi A et al (2017) A treatment protocol for management of bacterial and fungal malignant external otitis: a large cohort in Tehran. Iran Ann Otol Rhinol Laryngol 126(7):561–567. https://doi.org/10.1177/0003489417710473

    Article  Google Scholar 

  14. Marina S, Goutham MK, Rajeshwary A, Vadisha B, Devika T (2019) A retrospective review of 14 cases of malignant otitis externa. J Otol 14(2):63–66. https://doi.org/10.1016/j.joto.2019.01.003

    Article  Google Scholar 

  15. Rothholtz VS, Lee AD, Shamloo B, Bazargan M, Pan D, Djalilian HR (2008) Skull base osteomyelitis: the effect of comorbid disease on hospitalization. Laryngoscope 118(11):1917–1924. https://doi.org/10.1097/MLG.0b013e31817fae0d

    Article  Google Scholar 

  16. Stevens SM, Lambert PR, Baker AB, Meyer TA (2015) Malignant otitis externa: a novel stratification protocol for predicting treatment outcomes. Otol Neurotol 36(9):1492–1498. https://doi.org/10.1097/MAO.0000000000000839

    Article  Google Scholar 

  17. Soudry E, Hamzany Y, Preis M, Joshua B, Hadar T, Nageris BI (2011) Malignant external otitis: analysis of severe cases. Otolaryngol Head Neck Surg 144(5):758–762. https://doi.org/10.1177/0194599810396132

    Article  Google Scholar 

  18. Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY (2010) Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol 130(1):89–94. https://doi.org/10.3109/00016480902971247

    Article  Google Scholar 

  19. Ridder GJ, Breunig C, Kaminsky J, Pfeiffer J (2015) Central skull base osteomyelitis: new insights and implications for diagnosis and treatment. Eur Arch Otorhinolaryngol 272(5):1269–1276. https://doi.org/10.1007/s00405-014-3390-y

    Article  Google Scholar 

  20. Lee S, Hooper R, Fuller A, Turlakow A, Cousins V, Nouraei R (2008) Otogenic cranial base osteomyelitis: a proposed prognosis-based system for disease classification. Otol Neurotol 29(5):666–672. https://doi.org/10.1097/MAO.0b013e318179972f

    Article  CAS  Google Scholar 

  21. Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR (2007) Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope 117(5):907–910. https://doi.org/10.1097/MLG.0b013e318039b30f

    Article  Google Scholar 

  22. Soudry E, Joshua BZ, Sulkes J, Nageris BI (2007) Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg 133(10):1002–1004. https://doi.org/10.1001/archotol.133.10.1002

    Article  Google Scholar 

  23. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454. https://doi.org/10.1056/NEJM199902113400607

    Article  CAS  Google Scholar 

  24. Margulis I, Cohen-Kerem R, Roitman A, Gez-Reder H, Aviram A, Bitterman-Fisher S, Kugelman N, Doweck I (2022) Laboratory and imaging findings of necrotizing otitis externa are associated with pathogen type and disease outcome: a retrospective analysis. Ear Nose Throat J 19:1455613221080973. https://doi.org/10.1177/01455613221080973

    Article  Google Scholar 

  25. Durojaiye OC, Slucka A, Kritsotakis EI (2022) Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-022-04455-y

    Article  Google Scholar 

  26. Faizal B, Surendran B, Kumar M (2020) Comparative study of reliability of inflammatory markers over 18-FDG-PET CT scan in monitoring skull base osteomyelitis. Braz J Otorhinolaryngol. https://doi.org/10.1016/j.bjorl.2020.09.012

    Article  Google Scholar 

  27. Abu Eta R, Gavriel H, Stephen K, Eviatar E, Yeheskeli E (2018) The significance of tissue biopsy for fungi in necrotizing otitis externa. Eur Arch Otorhinolaryngol 275(12):2941–2945. https://doi.org/10.1007/s00405-018-5151-9

    Article  Google Scholar 

  28. Ali T, Meade K, Anari S, ElBadawey MR, Zammit-Maempel I (2010) Malignant otitis externa: case series. J Laryngol Otol 124(8):846–851. https://doi.org/10.1017/S0022215110000691

    Article  CAS  Google Scholar 

  29. Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3–4):259–265. https://doi.org/10.1111/j.1574-695X.1999.tb01397.x

    Article  CAS  Google Scholar 

  30. O’Sullivan TJ, Dickson RI, Blokmanis A, Roberts FJ, Kaan K (1978) The pathogenesis, differential diagnosis, and treatment of malignant otitis externa. J Otolaryngol 7(4):297–303

    CAS  Google Scholar 

  31. Lucente FE, Parisier SC, Som PM, Arnold LM (1982) Malignant external otitis: a dangerous misnomer? Otolaryngol Head Neck Surg 90(2):266–269. https://doi.org/10.1177/019459988209000223

    Article  CAS  Google Scholar 

  32. Lucente FE, Parisier SC, Som PM (1983) Complications of the treatment of malignant external otitis. Laryngoscope 93(3):279–281. https://doi.org/10.1288/00005537-198303000-00005

    Article  CAS  Google Scholar 

  33. Driscoll PV, Ramachandrula A, Drezner DA, Hicks TA, Schaffer SR (1993) Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis? Otolaryngol Head Neck Surg 109(4):676–679. https://doi.org/10.1177/019459989310900407

    Article  CAS  Google Scholar 

  34. Habra B, Mghari GE, Ansari NE (2018) Malignant external otitis in diabetic patients. Endocrinol Metab Int J. 6(3):173–175. https://doi.org/10.15406/emij.2018.06.00173

    Article  Google Scholar 

  35. Singh G, Pitoyo CW, Aditianingsih D, Rumende CM (2016) Risk factors for early invasive fungal disease in critically ill patients. Indian J Crit Care Med 20(11):633–639. https://doi.org/10.4103/0972-5229.194007

    Article  Google Scholar 

  36. Peleg AY, Weerarathna T, McCarthy JS, Davis TM (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 23(1):3–13. https://doi.org/10.1002/dmrr.682

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was done as a medical graduation thesis in Amir Alam Hospital which is affiliated with Tehran University of Medical Sciences.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

AZ contributed to conceptualization, methodology, investigation, writing—original draft, formal analysis, and data curation. AJ was involved in writing—review and editing, resources, and data curation. SD contributed to methodology, project administration, and formal analysis. MH contributed to resources and validation. AT performed validation. NK contributed to resources. NY did supervision.

Corresponding author

Correspondence to Nasrin Yazdani.

Ethics declarations

Conflict of interest

The authors have no competing interests to declare that are relevant to the content of this article.

Ethics approval

This study was approved by the Ethics Committee at Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1397.413). The clinical investigations were all conducted according to the principles expressed in the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zonnour, A., Jamshidi, A., Dabiri, S. et al. Predictive factors in treatment response of malignant external otitis. Eur Arch Otorhinolaryngol 280, 159–166 (2023). https://doi.org/10.1007/s00405-022-07478-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-022-07478-5

Keywords

Navigation